Abstract
Human herpesvirus-6 (HHV-6) is the etiological agent in most patients with a primary exanthem subitum infection, and it is often reactivated in immunosuppressed patients following hematopoietic stem cell transplantation (HSCT).1, 2 We report a female infant with ALL who developed primary HHV-6 infection during the early phase of allogeneic cord blood stem cell transplantation (CBSCT). The patient developed vesiculobullous eruptions that were indistinguishable from the skin lesions of acute GVHD. She was diagnosed with primary HHV-6 infection by virus isolation from the peripheral blood and detection of HHV-6 using the PCR. She was successfully treated with ganciclovir.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
